Sitacretin New Study during Last Ramadan 2012 -2013

Saturday, July 27, 2013

Under the slogan of our partnership with physicians and pharmacists “Partners in Health” , Ibn Alhaytham pharmaceutical industries sponsored a study about type II diabetic patients using Sitacretin Plus product ( Sitagliptin + Metformin ) last Ramadan during the year of 2012 in cooperation with Dr. Yaman Alsaied.

The study concluded that the use of Sitacretin plus by fasting patients in Ramadan is effective and safe especially in reducing hypoglycemic episodes.